TRILLIANT HEALTH RESEARCH

Research

Timely analysis on trends shaping the health economy, released weekly.

Timely trend analysis. Free in your inbox.

Receive weekly studies from Trilliant Health.

Figure 3_02.26.26
Featured Research

Cancer Survival Up 140% Since the Mid-1970s, but Mortality Improvements Are Uneven Across Racial Groups

Five-year cancer survival has reached a milestone of 70% – up from 49% in the mid-1970s. But mortality improvements are uneven: Black and American Indian and Alaska Native individuals have disproportionately high mortality rates despite, in some cases, lower overall incidence.

Read the Study
Studies

September 10, 2023

GLP-1 Utilization in New York City Is Not Correlated with Clinical Indication

GLP-1s can revolutionize clinical treatment of obesity and diabetes, but current utilization patterns are not correlated with clinical disease.

Sanjula Jain, Ph.D.

Studies

August 13, 2023

The Cell and Gene Patient Journey Is Determined by Access to Treatment Sites

Implementing comprehensive patient support programs could address barriers, including travel costs, compliance challenges and care coordination.

Sanjula Jain, Ph.D.

Studies

July 23, 2023

Employers Have a Critical Role in Containing U.S. Healthcare Spending

Health plan price transparency should compel health economy stakeholders to compete based on cost, quality and access, which are elements of value.

Sanjula Jain, Ph.D.

Studies

June 18, 2023

National Distribution Reveals Variation in Quality, Financial and Competitive Performance Among Renowned U.S. Hospitals

Accounting for factors such as services rendered, bed size and market characteristics is critical for identifying true hospital peers.

Sanjula Jain, Ph.D.

Studies

May 21, 2023

While Originally Intended for Consumers, Health Plan Price Transparency Will Ultimately Promote Value-Based Competition

Challenges in leveraging health plan price transparency data, including errors in cardiology rates, limit accessibility and analysis for data experts.

Sanjula Jain, Ph.D.

Studies

May 14, 2023

Patients Prescribed Drugs Like Ozempic® and Mounjaro® Have Increased Over 300%

The combination of demand and America’s obesity crisis has established telehealth companies to target the obesity and weight management market.

Sanjula Jain, Ph.D.

Studies

May 07, 2023

Eating Disorders Among Child and Adolescent Patients Incrementally Spiked Following the Pandemic’s Onset

The pandemic exacerbated social isolation and introduced disruptions to daily routines and structure, particularly for children and adolescents.

Sanjula Jain, Ph.D.

Studies

April 30, 2023

Life Science Investments Signal a Continued Focus on Oncology and Immunology

Oncology, immunology and rare disease continue to be therapeutic areas where companies have identified significant market opportunity.

Sanjula Jain, Ph.D.

Studies

March 19, 2023

Most Behavioral Health Patients, Particularly Those with Alcohol or Substance Use Disorder, Do Not Receive Follow-Up Care After an Emergency Department Visit

Most behavioral health patients, particularly those with alcohol or SUD, do not receive follow-up care after an emergency deptartment visit.

Sanjula Jain, Ph.D.

Interested in citing our research? Please follow this guide.

Mask group